依诺肝素低分子量肝素：其在全髋关节置换术后预防深静脉血栓形成中的应用。
Enoxaparine low molecular weight heparin: its use in the prevention of deep venous thrombosis following total hip replacement.
作者信息
Planes A, Vochelle N, Ferru J, Przyrowski D, Clerc J, Fagola M, Planes M
出版信息
Haemostasis. 1986;16(2):152-8. doi: 10.1159/000215285.
PMID:3710293
Abstract
UNLABELLED
The effect of Enoxaparin in the prevention of thromboembolism after total hip prosthesis has been controlled by phlebography. 228 consecutives patients were studied with 4 dose regimens: 60 mg once a day, 40 mg once a day, and 30 and 20 mg twice a day.
CONCLUSIONS
a total dose of 40 mg once a day or twice a day gives a rate of postoperative thrombosis of 8%.
摘要
未标记
依诺肝素预防全髋关节置换术后血栓栓塞的效果已通过静脉造影进行了对照研究。对228例连续患者采用4种剂量方案进行了研究：每日1次60毫克、每日1次40毫克以及每日2次30毫克和20毫克。
结论
每日1次或每日2次总剂量40毫克时，术后血栓形成率为8%。
Zotero 插件